NuVasive, Inc.

445 articles with NuVasive, Inc.

• NuVasive Announces First Quarter 2022 Financial Results

  5/4/2022

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced financial results for the quarter ended March 31, 2022.

• NuVasive Specialized Orthopedics Surpasses 100 Peer-Reviewed Publications of the Precice System for Limb Lengthening

  4/26/2022

  NuVasive, Inc. announced a milestone of more than 100 peer-reviewed publications of the Precice® System for conditions related to limb lengthening and reconstruction from NuVasive Specialized Orthopedics™.

• NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine

  4/21/2022

  NuVasive, Inc. today announced the NuVasive Simplify® Cervical Disc (Simplify Disc) two-level U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study data was recently published in the Journal of Neurosurgery: Spine.

• NuVasive Announces Conference Call and Webcast of First Quarter 2022 Results

  4/20/2022

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter results on Wednesday, May 4, 2022, after the close of the market.

• NuVasive Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Outlook

  2/23/2022

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended December 31, 2021.

• NuVasive to Participate in 42nd Annual Cowen Healthcare Conference

  2/22/2022

  NuVasive, Inc. announced that Chief Executive Officer Chris Barry will virtually present at the 42nd Annual Cowen Healthcare Conference on Tuesday, March 8, 2022 at 8:10 a.m. PT / 11:10 a.m. ET.

• NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2021 Results

  2/8/2022

  NuVasive, Inc. announced the Company will release its fourth quarter and full year 2021 results on Wednesday, February 23, 2022, after the close of the market.

• NuVasive Appoints Andrew C. Morton as Chief Human Resources Officer

  1/31/2022

  NuVasive, Inc. today announced the appointment of Andrew (Drew) C. Morton as senior vice president and chief human resources officer (CHRO) effective February 7, 2022 .

• NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with Company's Thoracolumbar Interbody Portfolio

  1/5/2022

  NuVasive, Inc. (NASDAQ: NUVA), today announced the Company received U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded indications of use for Attrax® Putty with its comprehensive thoracolumbar interbody portfolio for spine surgery.

• NuVasive to Participate in 40th Annual J.P. Morgan Healthcare Conference

  12/28/2021

  NuVasive, Inc. announced today that Chief Executive Officer Chris Barry will virtually present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 12:00 p.m. PT/ 3:00 pm ET.

• NuVasive to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference

  11/18/2021

  NuVasive, Inc. (NASDAQ: NUVA), announced today that NuVasive CEO J. Christopher Barry will virtually present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

• NuVasive Announces Third Quarter 2021 Financial Results

  11/9/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended September 30, 2021.

• NuVasive to Present at Credit Suisse 30th Annual Healthcare Conference

  11/1/2021

  NuVasive, Inc. announced today that management will virtually present at the Credit Suisse 30th Annual Healthcare Conference on Thursday, November 11, 2021 at 8:20 a.m. PT

• NuVasive to Sponsor and Participate in Society for Minimally Invasive Spine Surgery Annual Forum '21

  10/28/2021

  NuVasive, Inc. today announced it will sponsor and participate in the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum '21 in Las Vegas from October 28 to 30, 2021.

• NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery

  10/27/2021

  NuVasive, Inc. (NASDAQ: NUVA), today announced the upcoming release of a cutting-edge virtual reality (VR) training module for the NuVasive X360® system to complement its market-leading Clinical Professional Development (CPD) program.

• NuVasive Announces Conference Call and Webcast of Third Quarter 2021 Results

  10/25/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its third quarter 2021 earnings results on Tuesday, November 9, 2021, after the close of the market.

• NuVasive Announces First Commercial Cases Utilizing the Pulse Platform

  9/30/2021

  Leading U.S. surgeons and hospitals complete first commercial cases with NuVasive's integrated enabling technology platform for spine surgery

• NuVasive Partners with Scoliosis Research Society in Ongoing Double Diamond Sponsorship

  9/22/2021

  NuVasive, Inc. announced it will continue its long-standing partnership with the Scoliosis Research Society with a double diamond sponsorship and will attend the society's 56th Annual Meeting from September 22 to 25, 2021 in St. Louis, Mo.

• NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery

  9/9/2021

  NuVasive, Inc. (NASDAQ: NUVA), today announced the NuVasive Simplify® Cervical Disc one-level U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study data was recently published in the International Journal of Spine Surgery.

• NuVasive to Present at Upcoming Investor Conference - Aug 30, 2021

  8/30/2021

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that management will virtually present at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 9:30 a.m. PT / 12:30 p.m. ET.